PLIANT THERAPEUTICS, INC.·4

Jul 11, 4:41 PM ET

Ouimette Mike 4

4 · PLIANT THERAPEUTICS, INC. · Filed Jul 11, 2024

Insider Transaction Report

Form 4
Period: 2024-07-09
Ouimette Mike
General Counsel & Corp. Sec'y
Transactions
  • Award

    Common Stock

    2024-07-09+14,954101,700 total
Footnotes (1)
  • [F1]On July 28, 2022, the Reporting Person was granted 54,374 performance-vested stock units, the vesting of which were subject to the achievement of various pre-established performance criteria. On July 9, 2024, the Compensation Committee of the Issuer's Board of Directors certified the achievement of the performance criteria tied to the company's total shareholder return relative to the Nasdaq Biotechnology Index, resulting in the vesting of 14,954 shares.

Documents

1 file
  • 4
    wk-form4_1720730506.xmlPrimary

    FORM 4